Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

What is Parkinson’s disease? Parkinson’s disease (PD) is a type of movement disorder that occurs when nerve cells in the brain don’t produce enough of a chemical called dopamine. As a result, daily ...

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only ...

Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as ...